Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-03-20Clinical Trial Update: Effects of Exercise and Rivastigmine on Quality of Life of Alzheimer's Disease Patients [Phase 3]
A Phase 3 trial completed evaluating whether adding rivastigmine to an exercise program improves quality of life in Alzheimer's disease pati…
-
CLINICAL_TRIALS trial_result · 2012-03-14Clinical Trial Update: AAB-001 in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 trial update for AAB-001 (bapineuzumab) in patients with mild to moderate Alzheimer's disease. The study conducted by Janssen Alzhei…
-
CLINICAL_TRIALS trial_result · 2012-03-05Clinical Trial Update: An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease [Phase 3]
Phase 3 clinical trial evaluating memantine for safety and efficacy in agitated patients with moderate to severe Alzheimer's disease has com…
-
CLINICAL_TRIALS trial_result · 2012-03-05Clinical Trial Update: Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type [Phase 3]
Phase 3 clinical trial evaluating aripiprazole for psychosis in patients with Alzheimer's-type dementia completed; results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2012-03-05Clinical Trial Update: The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease [Phase 3]
Phase 3 trial evaluating safety and efficacy of neramexane in moderate-to-severe Alzheimer's disease has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-02-24Clinical Trial Update: Escitalopram Treatment of Patients With Agitated Dementia [Phase 4]
Phase 4 clinical trial update reporting completion of escitalopram treatment for agitation in patients with Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2012-02-08Clinical Trial Update: Evaluation of [18F] FEPPA and PET Imaging as a Marker of Inflammation in Subjects With Neurological Conditions [Phase 1]
Phase 1 study evaluating the PET imaging tracer [18F] FEPPA as a marker of inflammation in subjects with Alzheimer's disease, Parkinson's di…
-
CLINICAL_TRIALS trial_result · 2012-01-09Clinical Trial Update: Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease [Phase 3]
Phase 3 trial results for memantine in moderate-to-severe Alzheimer's disease were posted after the study was terminated.
-
CLINICAL_TRIALS trial_result · 2012-01-09Clinical Trial Update: Follow-up Study of the Alzheimer's Disease Anti-Inflammatory Prevention Trial
This document provides an update on the follow-up study of the Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT). The trial eva…
-
CLINICAL_TRIALS trial_result · 2012-01-06Clinical Trial Update: Lu AE58054 Added to Donepezil for the Treatment for Moderate Alzheimer's Disease [Phase 2]
A Phase 2 study evaluating adding Lu AE58054 to donepezil for moderate Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-01-06Clinical Trial Update: Mirtazapine in Alzheimer-associated Weight Loss
A completed clinical trial investigates the use of mirtazapine for weight loss associated with Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2011-12-20Clinical Trial Update: Safety and Tolerability of AFFITOPE AD03 [Phase 1]
Phase 1 trial assessing the safety and tolerability of AFFITOPE AD03 in Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-22Clinical Trial Update: Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease [Phase 2]
Phase 2 trial evaluating varenicline on cognition, safety, tolerability and pharmacokinetics in mild-to-moderate Alzheimer's disease was com…
-
CLINICAL_TRIALS trial_result · 2011-11-21Clinical Trial Update: Study to Evaluate the Safety, Pharmacokinetics and Tolerability of BMS-708163 [Phase 1]
Phase 1 study evaluating safety, pharmacokinetics, and tolerability of BMS-708163 in Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-17Clinical Trial Update: Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment [Phase 4]
Phase 4 trial evaluating rivastigmine alone and in combination with memantine in moderately severe Alzheimer's disease patients who did not …
-
CLINICAL_TRIALS trial_result · 2011-11-10Clinical Trial Update: The Dementia Study in Northern Norway [Phase 4]
A Phase 4 clinical trial studying dementia in Northern Norway focusing on Alzheimer disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-01Clinical Trial Update: Memantine - Communication Study [Phase 3]
A Phase 3 study of memantine for Alzheimer's disease has completed; the snippet provides no efficacy results.
-
CLINICAL_TRIALS trial_result · 2011-10-28Clinical Trial Update: Life From Vision in Alzheimer Disease
This entry notes the completion of a clinical trial sponsored by Assistance Publique - Hôpitaux de Paris, studying Life From Vision in patie…
-
CLINICAL_TRIALS trial_result · 2011-10-28Clinical Trial Update: Rivastigmine in Mild Alzheimer's Disease, FMRI Study [NA]
Completed clinical trial evaluating rivastigmine for mild Alzheimer's disease using functional MRI.
-
CLINICAL_TRIALS trial_result · 2011-10-03Clinical Trial Update: Neptune Krill Oil (NKO™) in Early Stage Alzheimer's Disease (MNEMOSYNE) [Phase 4]
Phase 4 clinical trial update shows completion of Neptune Krill Oil (NKO) testing in early-stage Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2011-09-13Clinical Trial Update: Memantine and Antipsychotics Use [Phase 4]
A Phase 4 trial evaluating memantine use with antipsychotics for Alzheimer's disease was terminated, with results posted on 2011-09-13.
-
CLINICAL_TRIALS trial_result · 2011-09-13Clinical Trial Update: Deep Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease [Phase 2]
Phase 2 study evaluating deep transcranial magnetic stimulation in Alzheimer's disease; the trial status is unknown.
-
CLINICAL_TRIALS trial_result · 2011-09-07Clinical Trial Update: Early Detection of Mild Cognitive Impairment in Individual Patients
This clinical trial update reports on a completed study evaluating early detection of mild cognitive impairment and Alzheimer's disease in i…
-
CLINICAL_TRIALS trial_result · 2011-08-23Clinical Trial Update: Study to Evaluate Safety, Tolerability and Immunogenicity of Vaccine (UB 311) in Subjects With Alzheimer's Disease [Phase 1]
Phase 1 trial update evaluating the safety, tolerability, and immunogenicity of the UB 311 vaccine in Alzheimer's disease patients has been …
-
CLINICAL_TRIALS trial_result · 2011-08-23Clinical Trial Update: Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease [Phase 2]
A Phase 2 safety and efficacy trial of ABT-089 in adults with mild to moderate Alzheimer's disease was terminated.